Table 3.
PrEP knowledge
| Pre- training (T1) |
Post- training (T2)* |
1 M follow- up (T3) |
|
|---|---|---|---|
| How effective is PrEP? | 61.1% | 91.7% | 89.2% |
| About how many people are using PrEP worldwide? | 32.5% | 77.1% | 58.0% |
| Out of 100 PrEP users, about how many would you expect to experience common side effects such as headache, nausea or weight loss? | 49.7% | 97.5% | 87.9% |
| How often should someone see a healthcare provider to monitor medication side effects, lab bloodwork, and STIs once they are using PrEP? | 53.5% | 91.7% | 79.0% |
| For PrEP users, which parts of their bodies should be tested for gonorrhea and chlamydia regularly? | 66.2% | 89.8% | 86.0% |
| One should not drink alcohol while on PrEP use. True or false? | 21.0% | 93.6% | 89.8% |
| Does TDF/FTC have approval by the China FDA to be used as PrEP in China | 17.2% | 77.1% | 66.2% |
| PrEP knowledge score | M (SD) | M (SD) | M (SD) |
| 3.78 (1.28) | 6.25 (1.00) | 5.65 (1.12) |
M: mean; SD: standard deviation.
Analyses restricted to participants who had heard of PrEP prior to T1 and completed all three surveys (n=157).
We used McNemar’s test to compare each item’s correct response rate at T2 versus T1. All increases were significant at p<0.0001, results not shown in the table.